Literature DB >> 16641999

TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity.

Fusheng Chen1, Hiroshi Hasegawa, Gerold Schmitt-Ulms, Toshitaka Kawarai, Christopher Bohm, Taiichi Katayama, Yongjun Gu, Nobuo Sanjo, Michael Glista, Ekaterina Rogaeva, Yosuke Wakutani, Raphaëlle Pardossi-Piquard, Xueying Ruan, Anurag Tandon, Frédéric Checler, Philippe Marambaud, Kirk Hansen, David Westaway, Peter St George-Hyslop, Paul Fraser.   

Abstract

The presenilin proteins (PS1 and PS2) and their interacting partners nicastrin, aph-1 (refs 4, 5) and pen-2 (ref. 5) form a series of high-molecular-mass, membrane-bound protein complexes that are necessary for gamma-secretase and epsilon-secretase cleavage of selected type 1 transmembrane proteins, including the amyloid precursor protein, Notch and cadherins. Modest cleavage activity can be generated by reconstituting these four proteins in yeast and Spodoptera frugiperda (sf9) cells. However, a critical but unanswered question about the biology of the presenilin complexes is how their activity is modulated in terms of substrate specificity and/or relative activities at the gamma and epsilon sites. A corollary to this question is whether additional proteins in the presenilin complexes might subsume these putative regulatory functions. The hypothesis that additional proteins might exist in the presenilin complexes is supported by the fact that enzymatically active complexes have a mass that is much greater than predicted for a 1:1:1:1 stoichiometric complex (at least 650 kDa observed, compared with about 220 kDa predicted). To address these questions we undertook a search for presenilin-interacting proteins that differentially affected gamma- and epsilon-site cleavage events. Here we report that TMP21, a member of the p24 cargo protein family, is a component of presenilin complexes and differentially regulates gamma-secretase cleavage without affecting epsilon-secretase activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641999     DOI: 10.1038/nature04667

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  133 in total

Review 1.  Cellular mechanisms of γ-secretase substrate selection, processing and toxicity.

Authors:  Gael Barthet; Anastasios Georgakopoulos; Nikolaos K Robakis
Journal:  Prog Neurobiol       Date:  2012-05-20       Impact factor: 11.685

2.  Alzheimer's disease: Selectively tuning gamma-secretase.

Authors:  Peter St George-Hyslop; Gerold Schmitt-Ulms
Journal:  Nature       Date:  2010-09-02       Impact factor: 49.962

3.  In vivo reconstitution of gamma-secretase in Drosophila results in substrate specificity.

Authors:  Denise Stempfle; Ritu Kanwar; Alexander Loewer; Mark E Fortini; Gunter Merdes
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

4.  In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitors.

Authors:  Ting Yang; Dilyara Arslanova; Xiaoyin Xu; Yue-Ming Li; Weiming Xia
Journal:  J Neurochem       Date:  2010-03-12       Impact factor: 5.372

Review 5.  p24 family proteins: key players in the regulation of trafficking along the secretory pathway.

Authors:  Noelia Pastor-Cantizano; Juan Carlos Montesinos; César Bernat-Silvestre; María Jesús Marcote; Fernando Aniento
Journal:  Protoplasma       Date:  2015-07-30       Impact factor: 3.356

Review 6.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Characterization of an atypical gamma-secretase complex from hematopoietic origin.

Authors:  Lisa Placanica; Jennifer W Chien; Yue-Ming Li
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

8.  Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity.

Authors:  Huifang Ma; Sylvain Lesné; Linda Kotilinek; Jill V Steidl-Nichols; Mathew Sherman; Linda Younkin; Steven Younkin; Colleen Forster; Nicolas Sergeant; André Delacourte; Robert Vassar; Martin Citron; Paulo Kofuji; Linda M Boland; Karen H Ashe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

9.  Evidence that CD147 modulation of beta-amyloid (Abeta) levels is mediated by extracellular degradation of secreted Abeta.

Authors:  Kulandaivelu S Vetrivel; Xulun Zhang; Xavier Meckler; Haipeng Cheng; Sungho Lee; Ping Gong; Kryslaine O Lopes; Ying Chen; Nobuhisa Iwata; Ke-Jie Yin; Jin-Moo Lee; Angèle T Parent; Takaomi C Saido; Yue-Ming Li; Sangram S Sisodia; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

Review 10.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.